Form 4: HeartBeam Director Plans Future Stock Sale

HeartBeam Director and 10% owner Mark E. Strome filed a Form 4 indicating a planned sale of 250,000 common shares on December 17, 2025, under a 10b5-1 plan.

Summary

• Mark E. Strome, a Director and 10% owner of HeartBeam, Inc., reported a planned transaction for the disposition of common stock.
• The transaction involves the sale of 250,000 shares of Common Stock at a weighted average price of $3.58 per share.
• The planned transaction date is December 17, 2025.
• Following this planned sale, Mr. Strome's beneficial ownership will be 2,900,000 shares.
• The remaining 2,900,000 shares are held indirectly through Mark E. Strome Living Trust and Strome Dynasty, LLC.
• The transaction is made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The planned sale of shares by a director, while significant, is being executed under a Rule 10b5-1 plan, which suggests it is a pre-scheduled transaction rather than a reaction to immediate, non-public information. This mitigates some of the negative sentiment typically associated with insider selling, but it still represents a reduction in the insider's equity exposure.

Negatives

• The planned sale of 250,000 shares by a director and 10% owner, even under a 10b5-1 plan, represents a reduction in direct exposure to the company's equity.
• While 10b5-1 plans are designed to avoid insider trading accusations, a significant planned sale can still be interpreted by some investors as a signal of the insider's long-term outlook or liquidity needs.

Future Outlook

The filing does not provide any forward-looking statements or guidance beyond the planned transaction details.

Industry Context

This filing is a standard insider trading report and does not provide information directly related to broader industry trends or competitors.

Related Party Transactions

• The reported securities are held indirectly by Mark E. Strome Living Trust and Strome Dynasty, LLC, entities for which Mr. Strome has the authority to vote and dispose of the securities. Mr. Strome disclaims beneficial ownership except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders may interpret the planned insider sale as a signal regarding the director's confidence or personal financial planning, potentially influencing market perception of the stock.

Key Dates

Recommendation

The reported transaction is a planned sale of 250,000 shares by a director and 10% owner under a Rule 10b5-1 plan, scheduled for December 17, 2025. While a reduction in insider ownership, the pre-arranged nature of the sale under a 10b5-1 plan often indicates personal financial planning rather than a reaction to new, adverse company developments. Therefore, this single transaction alone may not warrant a change in investment thesis, suggesting a 'hold' recommendation while monitoring future company performance and insider activity.

Keywords

HeartBeam, BEAT, Form 4, Insider Sale, Stock Transaction, Mark E. Strome, Director, 10% Owner, 10b5-1 Plan